-+ 0.00%
-+ 0.00%
-+ 0.00%

Kamada Receives FDA Approval For Houston Plasma Collection Center With Capacity Of 50,000 Liters And Up To $10M Annual Revenue Potential

Benzinga·08/11/2025 11:14:50
Listen to the news
  • Houston Center Cleared to Commence Commercial Sales of Normal Source Plasma
  • State of the Art Facility has Annual Collection Capacity of Approximately 50,000 Liters of Plasma and an Estimated Annual Revenue Contribution of $8 Million to $10 Million at its Full Capacity
  • Center is Structured to Collect Normal Source Plasma and Specialty Plasma, such as Anti-Rabies and Anti-D; Anticipated to be One of the Largest Sites for Specialty Plasma Collection in the U.S.